Procagen

AI technology is no longer an option, it’s a must

Procagen is applying AI technologies into our services in order to efficiently manage and analyze our big data For this, we are discovering and fostering AI researchers, and promoting product innovation through AI technology in various channels such as consulting with AI experts and collaborating with AI companies.  We are developing an AI SW as a medical device that calculates the current probability of having prostate cancer and this AI SW can be used for prostate biopsy decision-making process in PSA grey zone. (In progress of Class 3 medical device authorization by KFDA)